MANAGEMENT OF POSTERIOR CIRCULATION ISCHEMIC STROKE: A FOLLOW UP SURVEY OF 35 PATIENTS
Abstract
Introduction. Although so many studies and trials have been done on stroke and possible therapies for it, but the number of studies done specifically on posterior circulation stroke are very little.
Methods. A descriptive study was done on patients diagnosed clinically as posterior circulation infarct and confirmed their diagnosis by MRI. All the patients treated with intravenous heparin (1000 units per hour) replaced with warfarin which continued for 3 months and replaced by aspirin at the dose of 500 mg daily orally.
Findings. Thirty patients included in study. All of them are followed at least for six months. No death, no recurrence, no hemorrhagic transformation of ischemic stroke occurred with 95 percent confidence interval of zero percent to ten percent.
Conclusion. Our results showed that our regimen maybe able to decrease death and recurrence rate without increasing the risk of hemorrhagic transformation of ischemic stroke.
Methods. A descriptive study was done on patients diagnosed clinically as posterior circulation infarct and confirmed their diagnosis by MRI. All the patients treated with intravenous heparin (1000 units per hour) replaced with warfarin which continued for 3 months and replaced by aspirin at the dose of 500 mg daily orally.
Findings. Thirty patients included in study. All of them are followed at least for six months. No death, no recurrence, no hemorrhagic transformation of ischemic stroke occurred with 95 percent confidence interval of zero percent to ten percent.
Conclusion. Our results showed that our regimen maybe able to decrease death and recurrence rate without increasing the risk of hemorrhagic transformation of ischemic stroke.
Keywords
Hepalin, Warfarin, Aspirin, Posterior Circulation, Acute Ischemic Stroke